Evelo Biosciences is a clinical stage biotechnology company developing orally delivered product candidates that are designed to act on the small intestinal axis, SINTAX™, with systemic therapeutic effects. SINTAX plays a central role in governing the immune, metabolic, and neurological systems. The Company’s first product candidates are pharmaceutical preparations of single strains of microbes selected for their potential to offer defined pharmacological properties. Evelo’s therapies have the potential to be effective, safe, and affordable medicines to improve the lives of people with inflammatory diseases and cancer. Evelo currently has four product candidates in development: EDP1815, EDP1867, and EDP2939 for the treatment of inflammatory diseases and EDP1908 for the treatment of cancer. Evelo is advancing additional product candidates in other disease areas.
View Top Employees from Evelo Biosciences| Website | http://www.evelobio.com/ |
| Ticker | EVLO |
| Revenue | $20 million |
| Funding | $130 million |
| Employees | 106 (106 on RocketReach) |
| Founded | 2015 |
| Address | One Kendall Square, Building 600/700, Suite 7-201, Cambridge, Massachusetts 02139, US |
| Phone | (617) 577-0300 |
| Technologies |
JavaScript,
HTML,
PHP
+36 more
(view full list)
|
| Industry | Biotechnology Research, Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
| Competitors | Abivax, Alector, Annexon Biosciences, GlycoMimetics, Leap Therapeutics |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular Evelo Biosciences employee's phone or email?
Evelo Biosciences Questions
The Evelo Biosciences annual revenue was $20 million in 2024.
106 people are employed at Evelo Biosciences.
Evelo Biosciences is based in Cambridge, Massachusetts.
The NAICS codes for Evelo Biosciences are [3254, 32, 325, 32541].
The SIC codes for Evelo Biosciences are [283, 28].
Top Evelo Biosciences Employees
-
23
-
5+5+
-
35
-
45+
-
33
-
31
-
45+
Related Companies
